Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis
article
OA: closed
CC0
⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the impact of inhibiting prostaglandin E2 receptors EP2 and EP4 on the microRNA profile of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (72)
- A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: disease pathophysiology and the role of prostaglandins via openalex
- Functional MicroRNA Involved in Endometriosis via openalex
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
- Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis via openalex
- Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans via openalex
- Inhibition of CD36-Dependent Phagocytosis by Prostaglandin E2 Contributes to the Development of Endometriosis via openalex
- MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis via openalex
- MicroRNA-Regulated Pathways Associated with Endometriosis via openalex
- MicroRNAs and Endometriosis: Distinguishing Drivers from Passengers in Disease Pathogenesis via openalex
- MicroRNA Signature and Regulatory Functions in the Endometrium during Normal and Disease States via openalex
- MicroRNAs in endometriosis: biological function and emerging biomarker candidates† via openalex
- Molecular and preclinical basis to inhibit PGE <sub>2</sub> receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- Prostaglandin E <sub>2</sub> : the master of endometriosis? via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of repressed microRNAs in endometriosis via openalex
- Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1 via openalex
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases via openalex
- The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression via openalex
- W2148558073 via openalex
- W2154294588 via openalex
- W2160968516 via openalex
- W2160998038 via openalex
- W2164385268 via openalex
- W2258579859 via openalex
- W2551421447 via openalex
- W2783713671 via openalex
- W2800526221 via openalex
- W2896409065 via openalex
- W2903601092 via openalex
- W2904951482 via openalex
- W2938875427 via openalex
- W2991994521 via openalex
- W3001914828 via openalex
- W3008455426 via openalex
- W3023314008 via openalex
- W3057718939 via openalex
- W3092738015 via openalex
- W3137386751 via openalex
- W3154287339 via openalex
- W3163942848 via openalex
- W4211081176 via openalex
- W4241507333 via openalex
- W6692625587 via openalex
- W6759477748 via openalex
- W6794166411 via openalex
- W1963966397 via openalex
- W1969169755 via openalex
- W1978409298 via openalex
- W1981263394 via openalex
- W1983634176 via openalex
- W1984801458 via openalex
- W1991266606 via openalex
- W1992598298 via openalex
- W1997367235 via openalex
- W2019128172 via openalex
- W2028959659 via openalex
- W2040095832 via openalex
- W2046491405 via openalex
- W2067837272 via openalex
- W2070765029 via openalex
- W2103251660 via openalex
- W2108787980 via openalex
- W2121564486 via openalex
- W2121612337 via openalex
- W2123827665 via openalex
- W2124419959 via openalex
- W2138518792 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-04T00:34:36.779044+00:00
License: CC0
· commercial use OK